MoonLake Immunotherapeutics Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BVF INC/IL | 02/14/2025 | 19.75 M | $1.07 B | -9.19% | 31.40% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 8.49 M | $459.96 M | 0.00% | 13.50% |
| FMR LLC | 02/13/2025 | 6.34 M | $343.39 M | 28.10% | 10.08% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 3.34 M | $181.06 M | 12.19% | 5.32% |
| AVORO CAPITAL ADVISORS LLC | 02/14/2025 | 2.77 M | $150.00 M | 0.00% | 4.40% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 1.77 M | $95.97 M | 90.26% | 2.82% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 1.67 M | $90.68 M | 11.96% | 2.66% |
| HOLOCENE ADVISORS, LP | 02/14/2025 | 1.59 M | $85.84 M | 0.00% | 2.52% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 02/11/2025 | 1.31 M | $71.02 M | 12.36% | 2.09% |
| FEDERATED HERMES, INC. | 02/13/2025 | 1.28 M | $69.31 M | 13.25% | 2.04% |
| MARSHALL WACE, LLP | 02/13/2025 | 1.25 M | $67.43 M | 7.88% | 1.98% |
| POLAR CAPITAL HOLDINGS PLC | 02/14/2025 | 1.10 M | $59.57 M | 120.00% | 1.75% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 1.02 M | $55.37 M | 2.45% | 1.63% |
| FRED ALGER MANAGEMENT, LLC | 02/14/2025 | 673,773 | $36.48 M | 1.08% | 1.07% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 02/14/2025 | 649,590 | $35.18 M | 0.45% | 1.03% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 595,581 | $32.25 M | 2.55% | 0.95% |
| VOYA INVESTMENT MANAGEMENT LLC | 02/14/2025 | 448,860 | $24.31 M | 9.69% | 0.71% |
| FINEPOINT CAPITAL LP | 02/13/2025 | 447,935 | $24.26 M | 15.20% | 0.71% |
| CAMBER CAPITAL MANAGEMENT LP | 02/14/2025 | 441,000 | $23.88 M | 0.00% | 0.70% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 368,845 | $19.97 M | -7.97% | 0.59% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 346,617 | $18.77 M | -2.86% | 0.55% |
| SATURN V CAPITAL MANAGEMENT LLC | 02/14/2025 | 346,111 | $18.74 M | 15.77% | 0.55% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 332,522 | $18.01 M | 100.00% | 0.53% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 315,230 | $17.07 M | -9.69% | 0.50% |
| WOODLINE PARTNERS LP | 02/14/2025 | 293,535 | $15.89 M | 26.29% | 0.47% |
| 5AM VENTURE MANAGEMENT, LLC | 02/14/2025 | 282,313 | $15.29 M | 0.00% | 0.45% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 261,634 | $14.17 M | 21.22% | 0.42% |
| CANDRIAM S.C.A. | 02/07/2025 | 227,476 | $12.32 M | -4.82% | 0.36% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 208,896 | $11.31 M | 100.00% | 0.33% |
| BALYASNY ASSET MANAGEMENT L.P. | 02/14/2025 | 206,568 | $11.19 M | -42.65% | 0.33% |
| AMERIPRISE FINANCIAL INC | 02/14/2025 | 204,373 | $11.06 M | 28.33% | 0.32% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 200,000 | $10.83 M | -9.09% | 0.32% |
| VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 178,501 | $9.67 M | -18.06% | 0.28% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 155,000 | $8.39 M | -69.31% | 0.25% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 02/14/2025 | 142,702 | $7.73 M | 20.80% | 0.23% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 02/14/2025 | 136,438 | $7.39 M | -20.97% | 0.22% |
| VANGUARD GROUP INC | 02/11/2025 | 115,416 | $6.25 M | -1.97% | 0.18% |
| RICE HALL JAMES & ASSOCIATES, LLC | 01/31/2025 | 111,133 | $6.02 M | 47.26% | 0.18% |
| AXA S.A. | 02/14/2025 | 104,178 | $5.64 M | -0.16% | 0.17% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 100,000 | $5.42 M | 0.00% | 0.16% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 99,098 | $5.37 M | -48.40% | 0.16% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 98,719 | $5.35 M | 100.00% | 0.16% |
| STATE STREET CORP | 02/14/2025 | 91,545 | $4.96 M | 4.46% | 0.15% |
| HARBOR CAPITAL ADVISORS, INC. | 01/10/2025 | 79,648 | $4.31 M | 2.81% | 0.13% |
| CONGRESS ASSET MANAGEMENT CO /MA | 01/30/2025 | 72,993 | $3.95 M | 9.53% | 0.12% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 64,384 | $3.49 M | 100.00% | 0.10% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 58,950 | $3.19 M | 0.92% | 0.09% |
| RUSSELL INVESTMENTS GROUP, LTD. | 02/13/2025 | 55,890 | $3.03 M | -9.90% | 0.09% |
| PARKMAN HEALTHCARE PARTNERS LLC | 02/14/2025 | 54,294 | $2.94 M | -47.19% | 0.09% |
| ALPS ADVISORS INC | 02/13/2025 | 50,995 | $2.76 M | 16.35% | 0.08% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
MoonLake Immunotherapeutics institutional Ownership - FAQ's
During the previous two years, 136 institutional investors and hedge funds held shares of MoonLake Immunotherapeutics. The most heavily invested institutionals were:
BVF INC/IL: 19.75 M
Cormorant Asset Management, LP: 8.49 M
FMR LLC: 6.34 M
PRICE T ROWE ASSOCIATES INC /MD/: 3.34 M
Avoro Capital Advisors LLC: 2.77 M
Paradigm Biocapital Advisors LP: 1.77 M
100.55% of MoonLake Immunotherapeutics stock is owned by institutional investors.
Institutional investors have bought a total of 65.08 M shares in the last 24 months. This purchase volume represents approximately $3.37 B in transactions.